India to Turkey: Cyclosporine Export Trade Route

The India to Turkey Cyclosporine corridor is one of India's established pharmaceutical export routes, with 44 shipments documented worth a combined $2.7M USD. The route is dominated by CONCORD BIOTECH LIMITED, which alone accounts for roughly 87% of all export value, reflecting the consolidated nature of India's cyclosporine manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $62.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with cyclosporine's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 21.1%, placing it at rank #14 among India's top cyclosporine export destinations globally.

On the import side, key buyers of Indian cyclosporine in Turkey include PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED, TO THE ORDER OF ,, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LTD and 7 others. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED is the single largest importer with 14 shipments valued at $2.4M USD.

India's cyclosporine exports to Turkey are driven primarily by a handful of large-scale manufacturers. CONCORD BIOTECH LIMITED with 14 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CONCORD BIOTECH LIMITED, GENETEC LIFESCIENCES, CONCORD BIOTECH LTD — together account for 97% of total trade value on this route. The average shipment value of $62.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as cyclosporine 50mg conimune me 50mg cap-batch no.ohs23268ohs23269 manufacturing dt.oct-23 exp dt.sep-25 and cyclosporine 100mg conimune me 100mg cap-batch no.ohs23258ohs23259ohs23260- manufacturing dt.sep-23 exp dt.aug-25, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED is the largest importer with 14 shipments worth $2.4M USD — representing 87% of all cyclosporine imports from India on this route. A total of 10 buyers are active on this corridor.